Product category:
Process and OEM Valves
News Release from: Millipore | Subject: Aseptic valves
Edited by the Engineeringtalk Editorial
Team on 04 June 2004
Aseptic valves show long-term benefits
Many of the worlds leading pharmaceutical drug and food producers are currently moving over to Novaseptic when specifying aseptic valves for critical processes.
For years, users of Novaseptic's aseptic diaphragm valves customers have experienced positive results in terms of elimination of product hold-up, slashed maintenance times, reduced lifecycle costs and shortened CIP/SIP times when comparing their experiences with other "aseptic" valves currently in use throughout the pharmaceutical, biotechnology and food industries Many of the worlds leading pharmaceutical drug and food producers are currently moving over to Novaseptic when specifying aseptic valves for critical processes due to the aforementioned advantages
This article was originally published on Engineeringtalk on 25 May 2004 at 8.00am (UK)
Related stories
Mixer claims a revolution
The Cyclone is the appropriate name for the industry's first magnetically driven, bottom mounted, high shear mixer.
Sampling portfolio expanded
NovAseptic has added a new line of products to its NovaSeptum sampling portfolio to provide additional security and flexibility to an already unique product range.
However, tests to prove the life expectancy of the Novaseptic single-piece PTFE diaphragm have proved totally inconclusive.
This is because 3 years after the tests began, the diaphragms have shown no significant sign of damage that would result in a need for replacement.
The design of the Novaseptic valve body and diaphragm is unique.
Each is machined from a single piece of material.
The Novaseptic diaphragms' longevity is due to its rigidity and sanitary sealing mechanism, which minimises the wear that is usually associated with over compression and localised stresses exerted on thinner, multilayer type membrane diaphragms.
Further reading
Sampling system refits to older vessels
NovAseptic has produced a unique fitting to convert a normal Ingold vessel connection into a completely aseptic multi sampling and/or liquid inoculation unit.
Divert valve is the preferred choice
The Novaseptic dead-leg-free divert valve is becoming the preferred choice for pharmaceutical and biotechnology companies who require minimum product hold-up, fast heat-up time and minimum downtime.
Upstream mixer meets customer demands
The revolutionary Novaseptic USM upstream mixer has been developed in close co-operation with customers.
The initial capital cost of this single-piece diaphragm has proven to be a hurdle to some customers who traditionally use the "weir" type valves incorporating multilayer flat membrane seals.
One of these users, a large multinational pharmaceutical manufacturer, decided to move over to Novaseptic at one of its larger plants in Europe.
The company's aim was to shorten routine maintenance times and lifecycle costs related to replacement of diaphragms on their existing "weir" type valves that were installed on a liquid product distribution system.
Latest job opportunities
Field Service Engineer
Field Service Engineer, Service Engineer, Installation Engineer
Job Title: Field Service Engineer
Area: Cambridgeshire, Bedfordshire, Hertfordshire, Buckinghamshire, Essex, Middlesex, Surrey, Berkshire, Home Counties, South East
Salary: up to...
Field Service Engineer, Field Service, Service Engineer (Medical).
Field Service Engineer, Medical Field Service Engineer
Job Title: Field Service Engineer, Field Service, Service Engineer (Medical).
Area: Hampshire, Berkshire, Middlesex, Buckinghamshire, Hertfordshire, London, South East.
Salary:...
(Embedded) Electronics Design Engineers - Graduates to Senior
(Embedded) Electronics Design Engineers - Avon Ongoing business growth at this worl leading company has created a number of challenging and rewarding career opportunities to appeal to exceptional Electronics Design Engineers with varying levels of...
Media temperatures were between ambient and 135C and pressures between 1 and 3bar.
These valves were experiencing extreme conditions 24 hours per day, seven days per week.
Typically, during a year, they would expect failures, resulting in replacement of approximately 10% of diaphragms, and indeed all were replaced as a matter of routine after 12 months operation due to evidence of wear.
Since moving over to Novaseptic, the company has not experienced a single failure in 3 years of constant operation.
Again, all diaphragms are inspected for wear on an annual basis.
It goes without saying that this particular company now uses Novaseptic valves on all new critical aseptic process applications thanks to the reduction in maintenance costs.
Two further studies have been undertaken on behalf of Novaseptic to prove the durability of the PTFE diaphragm.
First, one of the world's leading suppliers of autoclaves and clean steam generation equipment, set out to test the NA valves' suitability for sterilisation processes as would generally be encountered within a typical pharmaceutical production application.
For the purpose of this test, a dry goods/porous load cycle was selected as the challenge method due to the extremes of temperature, pressure and vacuum that are typically present.
A single Novaseptic aseptic flow through valve was assembled within a test rig to undergo conditions of 3bar clean steam and a vacuum of 33mbar to simulate worst-case sterilisation conditions.
The valve was set to cycle continuously for 37 with full steam, and 37s at vacuum.
This test was continued for 8h per day up to a total of 894h - equivalent to almost 44,000 actuations.
A typical porous load sterilisation cycle would incorporate a worst-case maximum of 20 actuations per cycle.
On average between two and four sterilisation cycles are performed within a typical GMP application per day.
Even assuming 365 days per year productivity, the Novaseptic diaphragm underwent test cycles equivalent to between 1.5 and 3 years operation during the study.
On completion of the tests, the valve and diaphragm assembly was subjected to, and passed, a bubble point test using compressed air at 8bar.
The inspection of the PTFE diaphragm proved that there was no sign of physical damage or wear.
This particular manufacturer has historically specified replacement of the weir type, membrane diaphragms every 6 months as part of its preventive maintenance program.
A further study was undertaken by an Italian food specialties company to determine the expected life of the PTFE diaphragm.
This potential customer was considering the Novaseptic valve for process pipeline shutoff, takeoff and flow-through applications.
This plant produces betacaratene, antibiotics and other food ingredients from fermentation processes.
At the time of evaluation Novaseptic was unable to provide an accurate estimate of mean time between failures (MTBF) as the exact lifecycle was unavailable for this particular application.
The company in question set out to determine the MTBF by subjecting the valve and diaphragm to saturated steam at 3.8bar (150C), the valve being set to operate at between 32-34 strokes per minute, 24 hours per day.
After 12 days of continual operation, testing was ceased and the diaphragm inspected.
Again no physical signs of visible wear or damage were discovered.
As a result the customer in question installed Novaseptic valves on its new process system and continues to reap the benefits to this day.
Novaseptic's revolutionary diaphragm is used across the whole range of dead-leg-free aseptic process valve applications, and sizes (0.5 to 3in).
The NA valve range includes sample valves, tank outlet valves, WFI and clean steam takeoff valves, shutoff valves (all available with integral SIP/CIP satellite valve option) and a wide range of dead-leg-free process valve manifolds which are fast replacing the industry standard block valves which have been prominent over the past few years. Request a free brochure from Millipore ...
• Millipore: contact details and other news
• Email this article to a colleague
• Register for the free Engineeringtalk email newsletter
• Engineeringtalk Home Page

